Stockreport

CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma [Yahoo! Finance]

Candel Therapeutics, Inc.  (CADL) 
PDF company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that the U.S. Food and Drug Administration (FDA) grant [Read more]